Chronology of Occult and Gross Coagulopathy in Burn Patients
Sponsor
Medstar Health Research Institute (Other)
Overall Status
Completed
CT.gov ID
NCT01638481
Collaborator
United States Department of Defense (U.S. Fed)
158
1
107
1.5
Study Details
Study Description
Brief Summary
The purpose of the study is to identify the inflammatory and coagulation pathways and mechanisms that are activated immediately following burn injury, and how they affect outcomes in terms of organ failure and death. This study also addresses the limitation of current tests (PT, PTT, and platelet counts) employed to identify coagulation disturbances in severely injured patients both in a comprehensive and rapid manner.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
158 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Determining the Chronology of Occult and Gross Coagulopathy in Thermally Injured Patients: A Systems Biology Approach
Actual Study Start Date
:
Jul 1, 2012
Actual Primary Completion Date
:
Mar 1, 2017
Actual Study Completion Date
:
Jun 1, 2021
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Group #1 - Burns affecting less than 10% BSA
|
|
Group #2 - Burns affecting 10%-30% TBSA
|
|
Group #3 - Burns affecting 31%-50% TBSA
|
|
Group #4 - Burns affecting 51%-70% TBSA
|
|
Group #5 - Burns affecting >70% TBSA
|
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Patients, male or female, > or = 18 years of age, who arrive at Burn/Trauma Center with anticipated admission to The Burn Center within 4 hours of injury, with a thermal burn injury due to flash, flame, contact with hot object or liquid.
Exclusion Criteria:
- Patients suffering concomitant trauma that are in hemorrhagic shock. Patients with a preexisting history of coagulopathy, or currently taking anti-coagulants. Children and pregnant women. Patients with chemical or electrical injury. Patients who do not fluently speak either English or Spanish.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | MedStar Washington Hospital Center | Washington | District of Columbia | United States | 20010 |
Sponsors and Collaborators
- Medstar Health Research Institute
- United States Department of Defense
Investigators
- Principal Investigator: Jeffrey Shupp, MD, Medstar Health Research Institute
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Medstar Health Research Institute
ClinicalTrials.gov Identifier:
NCT01638481
Other Study ID Numbers:
- 58802-LS
First Posted:
Jul 11, 2012
Last Update Posted:
Feb 16, 2022
Last Verified:
Feb 1, 2022